TETRALYSAL 150 mg, hard capsule 56 capsules
Active ingredients: Lymecycline
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule56 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TETRALYSAL 150 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- film(s) thermosoudé(s) polyéthylène aluminium de 56 gélule(s)
- Marketing authorisation holder
- GALDERMA INTERNATIONAL
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 31 Aug 2012
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60061171CIP74158809CIP133400941588099Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LYMÉCYCLINEgélule | 226 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.